 BOCA RATON, Fla., June 08, 2021 GLOBE NEWSWIRE -- AzurRx BioPharma, Inc. NASDAQ: AZRX, AzurRx or the Company, a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, announced today that James Sapirstein, Chief Executive Officer of AzurRx, will present at the 2021 BIO Digital. The virtual conference is taking place June 10-11 and June 14-18, 2021. 